Pentagon directive targets nonpublic information, not trading itself

The Pentagon did not ban military personnel from prediction markets. It banned them from using what they know.

That distinction matters more than the headline suggests. A blanket trading prohibition would have been administratively clean and legally defensible under existing conflict-of-interest frameworks. What the directive actually does is narrower: it targets the use of nonpublic information specifically, which means the underlying question of whether military personnel can trade at all remains open. A prohibition on the misuse of information is an ethics rule. A prohibition on trading is a structural exclusion. The Pentagon chose the former.

The practical enforcement problem is significant. Insider trading law in commodities markets turns on whether a trader possessed material nonpublic information and whether that information was the basis for the trade. In equity markets, regulators have decades of case law and surveillance infrastructure to work with. In prediction markets, the architecture is different. Kalshi and Polymarket operate as CFTC-regulated exchanges, which means their surveillance obligations run to the CFTC, not to the Department of Defense. The Pentagon can issue a directive to its personnel. It cannot compel an exchange to flag military accounts, pull position data, or report suspicious activity to a commanding officer. The enforcement mechanism that would make this directive meaningful does not exist in any source I have reviewed.

This connects to something I have watched develop across multiple regulatory disputes: agencies reach for the available tool rather than the right one. At my previous firm, I worked on a matter where a federal agency issued conduct guidance to cover a jurisdictional gap it could not formally close. The guidance was real. The enforcement was hypothetical. The effect was largely reputational.

The CFTC's simultaneous action against Novig and ProphetX follows a different logic. The letters sent to both companies go to self-certification, which is a mechanism the CEA permits but does not make immune from agency review. When the CFTC tells an exchange that its self-certification contains false representations, it is not making a policy argument — it is making a legal one. The scorigami contract question is almost procedurally interesting: ProphetX maintains the agency asked for voluntary deferral, not withdrawal. That is a meaningful distinction in administrative law. Voluntary deferral pending review is not a final agency action. It is a request that preserves the company's right to argue compliance while the CFTC builds or abandons its case.

The broader pattern is a regulator under pressure from professional leagues and state gambling authorities, trying to draw a workable line between event contracts that convey price discovery and event contracts that function as parlay substitutes. Chairman Selig's public framing — that the CFTC is protecting consumers from manipulation — is correct as stated and incomplete as analysis. The micro contract restrictions track the NBA's own sportsbook restrictions almost exactly, which suggests the league's concerns are informing the agency's priorities in ways that are not fully visible in the public record.

Where I think the consensus read is wrong: the Pentagon directive will be treated as significant regulatory pressure on prediction markets, and it probably isn't. It has no enforcement mechanism that reaches the exchanges, no jurisdictional hook that gives the CFTC new authority, and no precedent that state attorneys general can cite. The CFTC letters to Novig and ProphetX carry more structural weight than the Pentagon's directive, because they operate inside a framework where the agency can actually act.